Effects of Modified Gegen Qinlian Decoction (葛根芩连汤) on Intestinal Mucosal Barrier and Epithelial Mesenchymal Transition in Ulcerative Colitis Model Mice
|更新时间:2026-02-03
|
Effects of Modified Gegen Qinlian Decoction (葛根芩连汤) on Intestinal Mucosal Barrier and Epithelial Mesenchymal Transition in Ulcerative Colitis Model Mice
Journal of Traditional Chinese MedicineVol. 65, Issue 24, Pages: 2580-2588(2024)
FANG Lihui,ZHANG Jiaqi,HU Lanshuo,et al.Effects of Modified Gegen Qinlian Decoction (葛根芩连汤) on Intestinal Mucosal Barrier and Epithelial Mesenchymal Transition in Ulcerative Colitis Model Mice[J].Journal of Traditional Chinese Medicine,2024,65(24):2580-2588.
FANG Lihui,ZHANG Jiaqi,HU Lanshuo,et al.Effects of Modified Gegen Qinlian Decoction (葛根芩连汤) on Intestinal Mucosal Barrier and Epithelial Mesenchymal Transition in Ulcerative Colitis Model Mice[J].Journal of Traditional Chinese Medicine,2024,65(24):2580-2588.DOI: 10.13288/j.11-2166/r.2024.24.012.
Effects of Modified Gegen Qinlian Decoction (葛根芩连汤) on Intestinal Mucosal Barrier and Epithelial Mesenchymal Transition in Ulcerative Colitis Model Mice
(葛根芩连汤) in treatment of ulcerative colitis (UC) from the view of intestinal mucosal epithelial barrier damage and epithelial mesenchymal transition.
Methods
2
Sixty male C57BL/6J mice were divided into blank group, model group, western medicine control group, and low-, medium-, and high-dose modified
Gegen Qinlian Decoction
groups, with 10 mice in each group. Except for the blank group, 3% dextran sodium sulfate (DSS) was used to induce colitis model by free drinking for 7 days, and on the first day of modelling, 6, 12, and 24 g/(kg·d) of modified
Gegen Qinlian Decoction
were given to the low-, medium-, and high-dose groups respectively, 5-aminosalicylic acid (5-ASA) 100 mg/(kg·d) given by gavage to western medicine control group, and 10 ml/kg distilled water were given to blank and model group by gavage, once a day for 7 days. Body mass of mice was recorded and disease activity index (DAI) scores were performed daily. The mice were anesthetized after 24h of the last administration and the colon was taken to observe the length of colon, HE staining was applied to observe the damage of colonic mucosa and score pathological states, Masson staining to detect the deposition of colonic collagen fibers, immunofluorescence to observe the distribution of F-actin in colonic mucosal epithelium, and immunohistochemistry to detect the expression of tight junction protein ZO-1, Occludin, E-cadherin and Vimentin.
Results
2
Compared with the blank group at the same time, the percentage of body mass of mice in the model group on day 7 of modelling significantly reduced and the DAI score was significantly increased (
P
<0.01); compared with the model group at the same time, the body mass of mice in the western medicine control group and all of modified
Gegen Qinlian Decoction
groups decreased, and the DAI scores of mice in the western medicine control group and the high-dose modified
Gegen Qinlian Decoction
group decreased (
P
<0.05 or
P
<0.01); compared with the same time of mice in the low-dos
Gegen Qinlian Decoction
group, the body mass of mice in the high-dose
Gegen Qinlian Decoction
group and the western medicine control group significantly elevated (
P
<0.05). Compared with the blank group, the length of the colon of mice in the model group was significantly shortened, the pathological score and the percentage of collagen area were significantly increased, the average fluorescence intensity of F-actin was reduced, the p
rotein levels of ZO-1, Occludin and E-cadherin in the colon tissue decreased, and the protein level of Vimentin elevated (
P
<0.01). Compared with the model group, the length of colon significantly increased, patholo-gical score, collagen area percentage decreased, ZO-1, Occludin, E-cadherin protein levels increased and Vimentin levels decreased in all medicated groups; the average fluorescence intensity of F-actin increased in the western medicine control group and the middle- and high-dose
Gegen Qinlian Decoction
groups (
P
<0.05 or
P
<0.01). Compared with the low-dose
Gegen Qinlian Decoction
group, the proportion of collagen fibre area in the middle-dose
Gegen Qinlian Decoction
group and the western medicine control group reduced; the mean fluorescence intensity of F-actin increased in the middle-dose
Gegen Qinlian Decoction
group; the protein levels of ZO-1 and E-cadherin increased in the western medicine control group, and the protein levels of ZO-1 increased in the high-dose
Gegen Qinlian Decoction
group (
P
<0.05). Compared with the medium-dose
Gegen Qinlian Decoction
group, the protein levels of ZO-1 elevated in the high-dose
Gegen Qinlian Decoction
group (
P
<0.05). Comapred with the high-dose
Gegen Qinlian Decoction
group, level of E-cadherin and Vimentin protein of the western medicine control group increased (
P
<0.05).
Conclusion
2
Modified
Gegen Qinlian Decoction
was able to reduce colonic inflammation and mucosal barrier damage and inhibit the process of epithelial mesenchymal transition in mice models of ulcerative colitis, which may be one of its action mechanisms .
YU Q , ZHU C , FENG S , et al . Economic burden and health care access for patients with inflammatory bowel diseases in China: web-based survey study [J]. J Med Internet Res , 2021 , 23 ( 1 ): e20629 .
WANG Y , ZHANG J , XU L , et al . Modified Gegen Qinlian decoction regulates Treg/Th17 balance to ameliorate dss-induced acute experimental colitis in mice by altering the gut microbiota [J]. Front Pharmacol , 2021 , 12 : 756978 . doi: 10.3389/fphar.2021.756978 http://dx.doi.org/10.3389/fphar.2021.756978 .
OKAYASU I , HATAKEYAMA S , YAMADA M , et al . A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice [J]. Gastroenterology , 1990 , 98 ( 3 ): 694 - 702 .
DONGRE A , WEINBERG RA . New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer [J]. Nat Rev Mol Cell Biol , 2019 , 20 ( 2 ): 69 - 84 .
LOVISA S , GENOVESE G , DANESE S . Role of epithelial-to-mesenchymal transition in inflammatory bowel disease [J]. J Crohns Colitis , 2019 , 13 ( 5 ): 659 - 668 .
ACLOQUE H , ADAMS MS , FISHWICK K , et al . Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease [J]. J Clin Invest , 2009 , 119 ( 6 ): 1438 - 1449 .
YANG J , ZHOU CZ , ZHU R , et al . MiR-200b-containing microvesicles attenuate experimental colitis associated intestinal fibrosis by inhibiting epithelial-mesenchymal transition [J]. J Gastroenterol Hepatol , 2017 , 32 ( 12 ): 1966 - 1974 .
Evaluation of Pulmonary Air-Blood Barrier Damage in Ulcerative Colitis Inflammatory Cancer Transformation Model Mice:Based on the "Lung-Intestine Correlation" Theory
Effect of Drug Pair Huangqi (Radix Astragali) & Baijiangcao (Herba Patriniae) on HT-29 Cell Inflammation Model by Regulating JAK1/STAT6/SOCS1 Signaling Pathway
Effects of Qingre Huashi Tiaoshu Formula (清热化湿调枢方) on Intestinal Mucosal Barrier and Expression of Related Proteins in Dextran Sodium Sulfate-induced Colitis Model Mice
Comparative Study on the Effects of Qingchang Wenzhong Decoction (清肠温中方) on the Intestinal Mucus Barrier in Conventional and Pseudo-Germ-Free Model Mice of Acute Ulcerative Colitis
Prevention and Treatment of the Relapse of Ulcerative Colitis Based on the Theory of Damp-Heat Latent Pathogen
Related Author
XU Huiyan
ZHANG Haimei
ZHAN Xinyu
WU Fanwu
JIA Yongsen
WU Chenxi
KONG Lingyu
YAN Xin
Related Institution
North China University of Science and Technology
Hebei Key Laboratory of Integrated Traditional Chinese and Western Medicine for Diabetes and Its Complications
Affiliated Hospital of North China University of Science and Technology
The Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Shandong University of Traditional Chinese Medicine